Tuesday, 2 January 2018

New drug approvals hit 21-year high in 2017

LONDON (Reuters) - U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light -- more than double the previous year -- while the figure also rose in the European Union.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)